share_log
Breakings ·  Dec 9 21:30
Revance Therapeutics Inc: Crown Will Commence a Tender Offer to Acquire All Outstanding Shares of Revance's Common Stock for $3.10 per Share in Cash
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment